FDA Inspection
Chartwell Pharmaceuticals Carmel LLCChartwell Pharmaceuticals Carmel LLC – FDA Inspection, Apr 25, 2013
Record Details
This FDA Inspection record concerns Chartwell Pharmaceuticals Carmel LLC, with an inspection on April 25, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 25, 2013
- Product Type
- Drugs
View Company Profile
ID · be506673-1f97-4629-8a35-e219e77841c3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 829380
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Chartwell Pharmaceuticals Carmel LLC
11| Date | Classification | Office | Project area |
|---|---|---|---|
| December 20, 2024 | OAI | New York District Office | Generic Drug Evaluation |
| January 11, 2024 | OAI | New York District Office | Generic Drug Evaluation |
| October 6, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chartwell Pharmaceuticals Carmel LLC
- FDA Inspection 1257461 - 2024-12-20
- FDA Inspection 1227007 - 2024-01-11
- FDA Inspection 1181090 - 2022-10-06
- FDA Inspection 1112833 - 2019-12-16
- FDA Inspection 1043109 - 2018-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.